← Eichor
Condition: Immunological Abnormalities Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immunological Abnormalities

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07416201Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT03361215Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Phase N/A · 1 location(s) · Vastra Gotaland Region · NCT05678374Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Phase 1/Phase 2 · 7 location(s) · New York Medical College · NCT04197596Genetic Basis of Immunodeficiency
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00055172Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Phase 1 · 3 location(s) · Children's National Research Institute · NCT04691622A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
Phase N/A · 11 location(s) · BioMarin Pharmaceutical · NCT06305234Impact of Thymectomy on Immunity in Infants After Cardiac Surgery
NA · 2 location(s) · Nantes University Hospital · NCT07019857Immunological Effects of Iron Supplementation in HHT Disease
NA · 1 location(s) · Hospices Civils de Lyon · NCT07111598Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06669949STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
NA · 1 location(s) · Gazi University · NCT06092528Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06519734Lentiviral Gene Therapy for CGD
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03645486Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Phase 1/Phase 2 · 4 location(s) · Washington University School of Medicine · NCT03128996Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema
Phase 3 · 32 location(s) · Pharvaris Netherlands B.V. · NCT07266805Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT02356653Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT05288790Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001405Natural History of Noncirrhotic Portal Hypertension
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT02417740Pathogenic Study of Adult Immune Enteropathies
Phase N/A · 4 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04280510Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06169150
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.